Real-world evidence for subcutaneous infliximab (CT-P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID-19) pandemic: A case series

被引:3
作者
Baraliakos, Xenofon [1 ]
Tsiami, Styliani [1 ]
Vijayan, Sooraj [2 ,3 ]
Jung, Haewon [4 ]
Barkham, Nick [2 ]
机构
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Royal Wolverhampton NHS Trust, Dept Rheumatol, New Crass Hosp, Wolverhampton Rd, Wolverhampton WV10 0QP, England
[3] SUT Acad Med Sci, Thiruvananthapuram, Kerala, India
[4] Celltrion Healthcare Co Ltd, Incheon, South Korea
来源
CLINICAL CASE REPORTS | 2022年 / 10卷 / 01期
关键词
COVID-19; CT-P13; SC; infliximab SC; infliximab subcutaneous; psoriatic arthritis; real-world evidence; MUSCULOSKELETAL DISEASES; RECOMMENDATIONS; MANAGEMENT;
D O I
10.1002/ccr3.5205
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The COVID-19 pandemic highlighted the benefits of subcutaneous (SC) administration for healthcare systems. The first SC intliximab, CT-P13 SC, was safe and effective for the treatment of psoriatic arthritis. Observed patient preferences for continuing CT-P13 SC suggest that patients receiving IV infliximab should be offered a switch to CT-P13 SC.
引用
收藏
页数:12
相关论文
共 24 条
  • [1] Biosimilar Development, 2020, EUROPEAN COMMISSION
  • [2] Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis
    Coates, Laura C.
    Kavanaugh, Arthur
    Mease, Philip J.
    Soriano, Enrique R.
    Acosta-Felquer, Maria Laura
    Armstrong, April W.
    Bautista-Molano, Wilson
    Bochncke, Wolf -Henning
    Campbc, Willemina
    Cauli, Alberto
    Espinoza, Luis R.
    FitzGerald, Oliver
    Gladman, Dafna D.
    Gottlieb, Alice
    Helliwel, Philip S.
    Husni, M. Elaine
    Love, Thorvardur J.
    Lubrano, Ennio
    McHugh, Neil
    Nash, Peter
    Ogdie, Alexis
    Orbai, Ana -Maria
    Parkinson, Andrew
    O'Sullivan, Denis
    Rosen, Cheryl F.
    Schwartzman, Sergio
    Siege, Evan L.
    Toloza, Sergio
    Tuong, William
    Ritchlin, Christopher T.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (05) : 1060 - 1071
  • [3] The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics
    Coates, Laura C.
    Tillett, William
    Chandler, David
    Helliwell, Philip S.
    Korendowych, Eleanor
    Kyle, Stuart
    McInnes, Iain B.
    Oliver, Susan
    Ormerod, Anthony
    Smith, Catherine
    Symmons, Deborah
    Waldron, Nicola
    McHugh, Neil J.
    [J]. RHEUMATOLOGY, 2013, 52 (10) : 1754 - 1757
  • [4] Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort
    Costa, Luisa
    Tasso, Marco
    Scotti, Nadia
    Mostacciuolo, Erika
    Girolimetto, Nicolo
    Foglia, Francesca
    del Puente, Antonio
    Scarpa, Raffaele
    Caso, Francesco
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (04)
  • [5] European Medicines Agency, 2021, REMS SUMM PROD CHAR
  • [6] European Medicines Agency, 2020, REM SUMM PROD CHAR
  • [7] European Medicines Agency, 2020, INFL SUMM PROD CHAR
  • [8] Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic
    George, Michael D.
    Venkatachalam, Shilpa
    Banerjee, Shubhasree
    Baker, Joshua F.
    Merkel, Peter A.
    Gavigan, Kelly
    Curtis, David
    Danila, Maria, I
    Curtis, Jeffrey R.
    Nowell, W. Benjamin
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (04) : 603 - 607
  • [9] Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry
    Glintborg, Bente
    Jensen, Dorte Vendelbo
    Engel, Sara
    Terslev, Lene
    Jensen, Mogens Pfeiffer
    Hendricks, Oliver
    Ostergaard, Mikkel
    Rasmussen, Simon Horskjaer
    Adelsten, Thomas
    Colic, Ada
    Danebod, Kamilla
    Kildemand, Malene
    Loft, Anne Gitte
    Munk, Heidi Lausten
    Pedersen, Jens Kristian
    Ostgard, Rene Drage
    Sorensen, Christian Moller
    Krogh, Niels Steen
    Agerbo, Jette
    Ziegler, Connie
    Hetland, Merete
    [J]. RMD OPEN, 2021, 7 (01):
  • [10] EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
    Gossec, Laure
    Baraliakos, Xenofon
    Kerschbaumer, Andreas
    de Wit, Maarten
    McInnes, Iain
    Dougados, Maxime
    Primdahl, Jette
    McGonagle, Dennis G.
    Aletaha, Daniel
    Balanescu, Andra
    Balint, Peter V.
    Bertheussen, Heidi
    Boehncke, Wolf-Henning
    Burmester, Gerd R.
    Canete, Juan D.
    Damjanov, Nemanja S.
    Kragstrup, Tue Wenzel
    Kvien, Tore K.
    Landewe, Robert B. M.
    Lories, Rik Jozef Urbain
    Marzo-Ortega, Helena
    Poddubnyy, Denis
    Rodrigues Manica, Santiago Andres
    Schett, Georg
    Veale, Douglas J.
    Van den Bosch, Filip E.
    van der Heijde, Desiree
    Smolen, Josef S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) : 700 - 712